| UniProt ID | MAFK_HUMAN | |
|---|---|---|
| UniProt AC | O60675 | |
| Protein Name | Transcription factor MafK | |
| Gene Name | MAFK | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 156 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves. [PubMed: 9150357 However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins, such as NFE2, NFE2L1/NRF1, NFE2L2/NRF2 and NFE2L3/NRF3, and recruiting them to specific DNA-binding sites] | |
| Protein Sequence | MTTNPKPNKALKVKKEAGENAPVLSDDELVSMSVRELNQHLRGLTKEEVTRLKQRRRTLKNRGYAASCRIKRVTQKEELERQRVELQQEVEKLARENSSMRLELDALRSKYEALQTFARTVARGPVAPSKVATTSVITIVKSTELSSTSVPFSAAS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTTNPKPNK ------CCCCCCCCC | 34.97 | 26699800 | |
| 3 | Phosphorylation | -----MTTNPKPNKA -----CCCCCCCCCC | 48.50 | 26699800 | |
| 9 | Ubiquitination | TTNPKPNKALKVKKE CCCCCCCCCCCCCCC | 64.72 | - | |
| 25 | Phosphorylation | GENAPVLSDDELVSM CCCCCCCCHHHHHHH | 43.16 | 29255136 | |
| 31 | Phosphorylation | LSDDELVSMSVRELN CCHHHHHHHHHHHHH | 20.26 | 29255136 | |
| 33 | Phosphorylation | DDELVSMSVRELNQH HHHHHHHHHHHHHHH | 15.54 | 29396449 | |
| 46 | Sumoylation | QHLRGLTKEEVTRLK HHHCCCCHHHHHHHH | 57.85 | - | |
| 46 | Ubiquitination | QHLRGLTKEEVTRLK HHHCCCCHHHHHHHH | 57.85 | - | |
| 46 | Sumoylation | QHLRGLTKEEVTRLK HHHCCCCHHHHHHHH | 57.85 | - | |
| 71 | Acetylation | YAASCRIKRVTQKEE HHHHHHEEECCCHHH | 22.82 | 20167786 | |
| 74 | Phosphorylation | SCRIKRVTQKEELER HHHEEECCCHHHHHH | 37.65 | - | |
| 76 | Ubiquitination | RIKRVTQKEELERQR HEEECCCHHHHHHHH | 43.73 | - | |
| 76 | Sumoylation | RIKRVTQKEELERQR HEEECCCHHHHHHHH | 43.73 | - | |
| 76 | Sumoylation | RIKRVTQKEELERQR HEEECCCHHHHHHHH | 43.73 | - | |
| 92 | Ubiquitination | ELQQEVEKLARENSS HHHHHHHHHHHHCCC | 53.26 | - | |
| 98 | Phosphorylation | EKLARENSSMRLELD HHHHHHCCCHHHHHH | 22.28 | 28555341 | |
| 99 | Phosphorylation | KLARENSSMRLELDA HHHHHCCCHHHHHHH | 21.36 | 25954137 | |
| 109 | Phosphorylation | LELDALRSKYEALQT HHHHHHHHHHHHHHH | 40.20 | 25954137 | |
| 110 | Ubiquitination | ELDALRSKYEALQTF HHHHHHHHHHHHHHH | 40.45 | 21890473 | |
| 110 | Ubiquitination | ELDALRSKYEALQTF HHHHHHHHHHHHHHH | 40.45 | 21890473 | |
| 110 | Sumoylation | ELDALRSKYEALQTF HHHHHHHHHHHHHHH | 40.45 | - | |
| 110 | Sumoylation | ELDALRSKYEALQTF HHHHHHHHHHHHHHH | 40.45 | - | |
| 111 | Phosphorylation | LDALRSKYEALQTFA HHHHHHHHHHHHHHH | 14.00 | - | |
| 120 | O-linked_Glycosylation | ALQTFARTVARGPVA HHHHHHHHHHCCCCC | 18.32 | 20068230 | |
| 130 | Sumoylation | RGPVAPSKVATTSVI CCCCCCCCCEECEEE | 34.53 | 28112733 | |
| 130 | Ubiquitination | RGPVAPSKVATTSVI CCCCCCCCCEECEEE | 34.53 | - | |
| 133 | Phosphorylation | VAPSKVATTSVITIV CCCCCCEECEEEEEE | 23.69 | - | |
| 133 | O-linked_Glycosylation | VAPSKVATTSVITIV CCCCCCEECEEEEEE | 23.69 | 20068230 | |
| 134 | Phosphorylation | APSKVATTSVITIVK CCCCCEECEEEEEEE | 15.97 | 20068230 | |
| 134 | O-linked_Glycosylation | APSKVATTSVITIVK CCCCCEECEEEEEEE | 15.97 | 20068230 | |
| 134 | O-linked_Glycosylation | APSKVATTSVITIVK CCCCCEECEEEEEEE | 15.97 | 30059200 | |
| 135 | O-linked_Glycosylation | PSKVATTSVITIVKS CCCCEECEEEEEEEC | 13.73 | 20068230 | |
| 138 | O-linked_Glycosylation | VATTSVITIVKSTEL CEECEEEEEEECCCC | 19.98 | 20068230 | |
| 142 | O-linked_Glycosylation | SVITIVKSTELSSTS EEEEEEECCCCCCCC | 19.07 | 20068230 | |
| 146 | O-linked_Glycosylation | IVKSTELSSTSVPFS EEECCCCCCCCCCCC | 25.90 | 20068230 | |
| 147 | O-linked_Glycosylation | VKSTELSSTSVPFSA EECCCCCCCCCCCCC | 37.01 | 20068230 | |
| 153 | O-linked_Glycosylation | SSTSVPFSAAS---- CCCCCCCCCCC---- | 19.49 | 30059200 | |
| 153 | O-linked_Glycosylation | SSTSVPFSAAS---- CCCCCCCCCCC---- | 19.49 | 20068230 | |
| 156 | O-linked_Glycosylation | SVPFSAAS------- CCCCCCCC------- | 40.23 | 20068230 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MAFK_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MAFK_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MAFK_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NF2L2_HUMAN | NFE2L2 | physical | 10747902 | |
| KAT6A_HUMAN | KAT6A | physical | 17083329 | |
| BACH1_HUMAN | BACH1 | physical | 19011633 | |
| HDAC1_HUMAN | HDAC1 | physical | 18241676 | |
| HDAC2_HUMAN | HDAC2 | physical | 18241676 | |
| HDAC3_HUMAN | HDAC3 | physical | 18241676 | |
| TF65_HUMAN | RELA | physical | 18241676 | |
| NF2L2_HUMAN | NFE2L2 | physical | 21988832 | |
| NF2L2_HUMAN | NFE2L2 | physical | 23737527 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY. | |